Melanoma, New England Journal of Medicine, vol.355, issue.1, pp.51-65, 2006. ,
DOI : 10.1056/NEJMra052166
Death receptors and melanoma resistance to apoptosis, Oncogene, vol.22, issue.20, pp.3152-3161, 2003. ,
DOI : 10.1038/sj.onc.1206456
Apoptosis and melanoma: how new insights are effecting the development of new therapies for melanoma, Current Opinion in Oncology, vol.18, issue.2, pp.189-196, 2006. ,
DOI : 10.1097/01.cco.0000208794.24228.9f
Novel Anti-Melanoma Immunotherapies: Disarming Tumor Escape Mechanisms, Clinical and Developmental Immunology, vol.24, issue.2, 2012. ,
DOI : 10.1056/NEJMoa1001294
Structure and function of a large family of animal lectins, J Biol Chem, vol.269, pp.20807-20810, 1994. ,
Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival, Cellular and Molecular Life Sciences, vol.64, issue.13, pp.1679-1700, 2007. ,
DOI : 10.1007/s00018-007-7044-8
Clusters, bundles, arrays and lattices: novel mechanisms for lectin???saccharide-mediated cellular interactions, Current Opinion in Structural Biology, vol.12, issue.5, pp.616-639, 2002. ,
DOI : 10.1016/S0959-440X(02)00364-0
Nucleocytoplasmic lectins, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1673, issue.1-2, pp.75-93, 2004. ,
DOI : 10.1016/j.bbagen.2004.03.013
Galectins as modulators of tumour progression, Nature Reviews Cancer, vol.19, issue.1, pp.29-41, 2005. ,
DOI : 10.1038/nrc1275
The Role of Galectins in Protein Trafficking, Traffic, vol.342, issue.10, pp.1405-1418, 2009. ,
DOI : 10.1111/j.1600-0854.2009.00960.x
URL : https://hal.archives-ouvertes.fr/hal-00493282
Turning 'sweet' on immunity: galectin???glycan interactions in immune tolerance and inflammation, Nature Reviews Immunology, vol.16, issue.5, pp.338-52, 2009. ,
DOI : 10.1038/nri2536
Cloning, expression, and chromosome mapping of human galectin-7, J Biol Chem, vol.270, pp.5823-5829, 1995. ,
Galectin-7, a Human 14-kDa S-Lectin, Specifically Expressed in Keratinocytes and Sensitive to Retinoic Acid, Developmental Biology, vol.168, issue.2, pp.259-271, 1995. ,
DOI : 10.1006/dbio.1995.1078
Galectin-7, a marker of all types of stratified epithelia, Differentiation, vol.63, issue.3, pp.159-168, 1998. ,
DOI : 10.1046/j.1432-0436.1998.6330159.x
Suppression of Tumor Growth by Galectin-7 Gene Transfer, Cancer Research, vol.64, issue.16, pp.5672-5676, 2004. ,
DOI : 10.1158/0008-5472.CAN-04-0985
A model for p53- induced apoptosis, Nature, vol.389, issue.6648, pp.300-305, 1997. ,
DOI : 10.1038/38525
Profiling Protein Markers Associated with the Sensitivity to Concurrent Chemoradiotherapy in Human Cervical Carcinoma, Journal of Proteome Research, vol.8, issue.8, pp.3969-3976, 2009. ,
DOI : 10.1021/pr900287a
Gene expression changes associated with chemically induced rat mammary carcinogenesis, Molecular Carcinogenesis, vol.19, issue.2, pp.204-215, 1997. ,
DOI : 10.1002/(SICI)1098-2744(199710)20:2<204::AID-MC7>3.0.CO;2-M
Galectin 7 (p53-Induced Gene 1): A New Prognostic Predictor of Recurrence and Survival in Stage IV Hypopharyngeal Cancer, Annals of Surgical Oncology, vol.113, issue.7, pp.999-1009, 2006. ,
DOI : 10.1245/ASO.2006.08.033
A Novel Function for Galectin-7: Promoting Tumorigenesis by Up-regulating MMP-9 Gene Expression, Cancer Research, vol.65, issue.12, pp.5205-5210, 2005. ,
DOI : 10.1158/0008-5472.CAN-05-0134
Galectin-7 in Lymphoma: Elevated Expression in Human Lymphoid Malignancies and Decreased Lymphoma Dissemination by Antisense Strategies in Experimental Model, Cancer Research, vol.67, issue.6, pp.2824-2829, 2007. ,
DOI : 10.1158/0008-5472.CAN-06-3891
Overexpression of Galectin-7, A Myoepithelial Cell Marker, Enhances Spontaneous Metastasis of Breast Cancer Cells, The American Journal of Pathology, vol.176, issue.6, pp.3023-3031, 2010. ,
DOI : 10.2353/ajpath.2010.090876
URL : https://hal.archives-ouvertes.fr/pasteur-00819591
On the role of galectin-3 in cancer apoptosis, Apoptosis, vol.55, issue.2, pp.267-275, 2005. ,
DOI : 10.1007/s10495-005-0801-y
Galectin-7 in the Control of Epidermal Homeostasis after Injury, Molecular Biology of the Cell, vol.19, issue.12, pp.5541-5549, 2008. ,
DOI : 10.1091/mbc.E08-02-0166
URL : https://hal.archives-ouvertes.fr/hal-00326943
Biological behavior of malignant melanoma cells correlated to their survival in vivo, Cancer Res, vol.35, pp.218-224, 1975. ,
Multiple HLA Class II-Restricted Melanocyte Differentiation Antigens Are Recognized by Tumor-Infiltrating Lymphocytes from a Patient with Melanoma, The Journal of Immunology, vol.169, issue.10, pp.6036-6047, 2002. ,
DOI : 10.4049/jimmunol.169.10.6036
The metastatic characteristics of murine lymphoma cell lines in vivo are manifested after target organ invasion, Blood, vol.91, pp.623-629, 1998. ,
Monitoring mmp-9 gene expression in stromal cells using a novel transgenic mouse model, Cellular and Molecular Life Sciences, vol.66, issue.5, pp.783-91, 2012. ,
DOI : 10.1007/s00018-011-0777-4
URL : https://hal.archives-ouvertes.fr/pasteur-00819060
Novel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions, Clinical Cancer Research, vol.11, issue.20, pp.7234-7242, 2005. ,
DOI : 10.1158/1078-0432.CCR-05-0683
Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas, Cancer Biology & Therapy, vol.4, issue.9, pp.1018-1029, 2005. ,
DOI : 10.4161/cbt.4.9.2165
Seven Novel and Stable Translocations Associated with Oncogenic Gene Expression in Malignant Melanoma, Neoplasia, vol.7, issue.4, pp.303-311, 2005. ,
DOI : 10.1593/neo.04514
NAG-1 up-regulation mediated by EGR-1 and p53 is critical for quercetin-induced apoptosis in HCT116 colon carcinoma cells, Apoptosis, vol.275, issue.5A, pp.411-421, 2007. ,
DOI : 10.1007/s10495-006-0576-9
Regulation of Radiation-Induced Apoptosis by Early Growth Response-1 Gene in Solid Tumors, Current Cancer Drug Targets, vol.4, issue.1, pp.43-52, 2004. ,
DOI : 10.2174/1568009043481704
A distinctive role for galectin-7 in cancer ?, Frontiers in Bioscience, vol.17, issue.1, pp.438-450, 2012. ,
DOI : 10.2741/3937
URL : https://hal.archives-ouvertes.fr/pasteur-01009758
Changes in Galectin-7 and Cytokeratin-19 Expression during the Progression of Malignancy in Thyroid Tumors: Diagnostic and Biological Implications, Modern Pathology, vol.15, issue.12, pp.1294-1301, 2002. ,
DOI : 10.1097/01.MP.0000037306.19083.28
Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis, BMC Cancer, vol.13, issue.2, p.290, 2010. ,
DOI : 10.1038/sj.onc.1206631
Significance of galectins-1, -3, -4 and -7 in the progression of squamous cell carcinoma of the tongue, Pathology - Research and Practice, vol.207, issue.4, pp.236-240, 2011. ,
DOI : 10.1016/j.prp.2011.02.004
Cypermethrin exposure leads to regulation of proteins expression involved in neoplastic transformation in mouse skin, PROTEOMICS, vol.23, issue.22, pp.4411-4421, 2011. ,
DOI : 10.1002/pmic.201100233
Mitochondrial proteomic approach reveals galectin-7 as a novel BCL-2 binding protein in human cells, Molecular Biology of the Cell, vol.22, issue.7, pp.999-1013, 2011. ,
DOI : 10.1091/mbc.E10-06-0534
BCL2 inhibits cell adhesion, spreading, and motility by enhancing actin polymerization, Cell Research, vol.269, issue.4, pp.458-469, 2010. ,
DOI : 10.1073/pnas.68.11.2799
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848692